These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29442101)

  • 1. A molecular dynamics study of the complete binding process of meropenem to New Delhi metallo-β-lactamase 1.
    Duan J; Hu C; Guo J; Guo L; Sun J; Zhao Z
    Phys Chem Chem Phys; 2018 Feb; 20(9):6409-6420. PubMed ID: 29442101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolysis of cephalexin and meropenem by New Delhi metallo-β-lactamase: the substrate protonation mechanism is drug dependent.
    Das CK; Nair NN
    Phys Chem Chem Phys; 2017 May; 19(20):13111-13121. PubMed ID: 28489087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1.
    Zhu K; Lu J; Ye F; Jin L; Kong X; Liang Z; Chen Y; Yu K; Jiang H; Li JQ; Luo C
    Biochem Biophys Res Commun; 2013 Feb; 431(1):2-7. PubMed ID: 23313491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantum mechanics/molecular mechanics study on the hydrolysis mechanism of New Delhi metallo-β-lactamase-1.
    Zhu K; Lu J; Liang Z; Kong X; Ye F; Jin L; Geng H; Chen Y; Zheng M; Jiang H; Li JQ; Luo C
    J Comput Aided Mol Des; 2013 Mar; 27(3):247-56. PubMed ID: 23456591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biapenem inactivation by B2 metallo β-lactamases: energy landscape of the post-hydrolysis reactions.
    Gatti DL
    PLoS One; 2012; 7(1):e30079. PubMed ID: 22272276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-active site mutation (Q123A) in New Delhi metallo-β-lactamase (NDM-1) enhanced its enzyme activity.
    Ali A; Azam MW; Khan AU
    Int J Biol Macromol; 2018 Jun; 112():1272-1277. PubMed ID: 29454953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulation studies of novel β-lactamase inhibitor.
    Ul Haq F; Abro A; Raza S; Liedl KR; Azam SS
    J Mol Graph Model; 2017 Jun; 74():143-152. PubMed ID: 28432959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition.
    King DT; Worrall LJ; Gruninger R; Strynadka NC
    J Am Chem Soc; 2012 Jul; 134(28):11362-5. PubMed ID: 22713171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Delhi metallo-β-lactamase I: substrate binding and catalytic mechanism.
    Zheng M; Xu D
    J Phys Chem B; 2013 Oct; 117(39):11596-607. PubMed ID: 24025144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into mode of binding of Meropenem to CTX-M-15 type β-lactamase.
    Maryam L; Khan AU
    Int J Biol Macromol; 2017 Mar; 96():78-86. PubMed ID: 27986632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asp120Asn mutation impairs the catalytic activity of NDM-1 metallo-β-lactamase: experimental and computational study.
    Chen J; Chen H; Zhu T; Zhou D; Zhang F; Lao X; Zheng H
    Phys Chem Chem Phys; 2014 Apr; 16(14):6709-16. PubMed ID: 24584846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzoinformatics study for prediction of efficacies of three novel penem antibiotics against New Delhi metallo-β-lactamase-1 bacterial enzyme.
    Ansari MA; Shaikh S; Shakil S; Rizvi SM
    Interdiscip Sci; 2014 Sep; 6(3):208-15. PubMed ID: 25205498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined models of New Delhi metallo-beta-lactamase-1 with inhibitors: an QM/MM modeling study.
    Wang YT; Cheng TL
    J Biomol Struct Dyn; 2016 Oct; 34(10):2214-23. PubMed ID: 26488313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of conserved residues in the catalytic activity of NDM-1: an approach involving site directed mutagenesis and molecular dynamics.
    Ali A; Kumar R; Iquebal MA; Jaiswal S; Kumar D; Khan AU
    Phys Chem Chem Phys; 2019 Aug; 21(32):17821-17835. PubMed ID: 31373340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase.
    Marcoccia F; Leiros HS; Aschi M; Amicosante G; Perilli M
    PLoS One; 2018; 13(1):e0189686. PubMed ID: 29293526
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Rahman M; Khan MKA
    J Biomol Struct Dyn; 2020 Apr; 38(7):2093-2103. PubMed ID: 31184285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metallo-beta-lactamase enzyme in action: crystal structures of the monozinc carbapenemase CphA and its complex with biapenem.
    Garau G; Bebrone C; Anne C; Galleni M; Frère JM; Dideberg O
    J Mol Biol; 2005 Jan; 345(4):785-95. PubMed ID: 15588826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1.
    Christopeit T; Albert A; Leiros HS
    Bioorg Med Chem; 2016 Jul; 24(13):2947-2953. PubMed ID: 27184103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time monitoring of New Delhi metallo-β-lactamase activity in living bacterial cells by 1H NMR spectroscopy.
    Ma J; McLeod S; MacCormack K; Sriram S; Gao N; Breeze AL; Hu J
    Angew Chem Int Ed Engl; 2014 Feb; 53(8):2130-3. PubMed ID: 24458501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling.
    Wang X; Yang Y; Gao Y; Niu X
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.